RNCOS Releases a New Report- Russian Pharma Sector Analysis
RNCOS has recently added a new Market Research Report titled, "Russian Pharma Sector Analysis" to its report gallery. The report provides an extensive research and objective analysis on the growing demand of pharmaceuticals in Russia.


    /Pharmaceutical News Articles/ - NEW DELHI, INDIA, September 10, 2008 - RNCOS has recently added a new Market Research Report titled, "Russian Pharma Sector Analysis" to its report gallery. According to the report, the Russian pharmaceutical market grew at a slow pace in 2007 but it still is attractive as compared to previous years that recorded no-so-impressive performance due to the state segment. In the Russian pharma market, both the retail segment and parapharmaceutical market registered double-digit growth in sales value, with parapharmaceutical recording the highest growth rate and retail segment contributing the maximum share in sales value terms.

This research report provides an extensive research and objective analysis on the growing demand of pharmaceuticals in Russia and presents a clear picture of the country's healthcare and pharmaceutical market. It covers Russian demographics, structure of healthcare sector, size and growth of pharmaceutical market, leading drugs, segment-wise break up, and information on major therapy areas to give strategic insight into the market. This report briefly discusses the major players operating in each segment of the market. The share of imported and domestic drugs, RX and OTC drugs, and sales structure by ATC group has also been analyzed in context of the Russian pharmaceutical market.

Key Research Findings

- The Russian pharmaceutical market grew 16% in 2007 as compared to 2006.
- State segment grew at a slower rate while the parapharmaceutical and commercial segments recorded impressive growth rates in 2007.
- In 2007, new drugs segment increased at fast pace as more than 230 new drug trade names appeared in the Russian pharmaceutical market.
- In 2007, Sanofi-Aventis was the leader of the retail sales among the drug manufacturers in commercial drug market segment.
- The consumption value provided by the State Reimbursement Program (DLO) decreased in 2007 due to diminishing requirement.
- The Russian pharmaceutical market is forecasted to grow at a CAGR of 14.36% by 2012.

Key Issues Analyzed in the Report

- Where does the Russian pharmaceutical market stand in comparison to other key global markets?
- What is the market size of various segments in the Russian pharmaceutical industry?
- What is the proportion of domestic and imported drugs in each segment?
- What are the opportunities that will emerge in future for the market?
- Who are the major players in the Russian pharmaceutical market?

For the purpose of this report, the Russian pharmaceutical market has been considered to consist of the following segments:

- Commercial drugs market;
- State segment (DLO programme and Hospital Segment)
- Parapharmaceutical segment (Food Supplements and Cosmetics)

For more information visit: http://www.rncos.com/Report/IM548.htm
Current Industry News: http://www.rncos.com/Blog/

Further Related Resources:


Press Release Contact Information:

Shushmul Maheshwari
RNCOS
CEO
29, 1st Floor, Patparganj Industrial area
Delhi, New Delhi
India 110092
Voice: 91-11-4214-1229
Fax: 91-11-4214-1229
Website: Visit Our Website